PhaseBio Pharmaceuticals (NASDAQ:PHAS) Issues Earnings Results, Beats Estimates By $0.14 ...

Retrieved on: 2019-06-01 21:51:32

Tags for this article:

Click the tags to see associated articles and topics

PhaseBio Pharmaceuticals (NASDAQ:PHAS) Issues Earnings Results, Beats Estimates By $0.14 .... View article details on hiswai:

Excerpt

<div>Finally, <b>Schonfeld Strategic Advisors</b> LLC acquired a new stake in PhaseBio Pharmaceuticals in the 1st quarter valued at about $600,000. Institutional ...</div>

Article found on:

View Original Article